The Anti-Hypertensive Drugs Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Anti-Hypertensive Drugs Market:
https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report
According to The Business Research Company’s Anti-Hypertensive Drugs Global Market Report 2024, The anti-hypertensive drugs market size has grown steadily in recent years. It will grow from $35.8 billion in 2023 to $36.7 billion in 2024 at a compound annual growth rate (CAGR) of 2.5%. The growth in the historic period can be attributed to environmental and lifestyle influences, historical market competition, historical treatment preferences, economic conditions, historical global health trends.
The anti-hypertensive drugs market size is expected to see steady growth in the next few years. It will grow to $40.28 billion in 2028 at a compound annual growth rate (CAGR) of 2.4%. The growth in the forecast period can be attributed to cost-effectiveness and affordability, emerging therapeutic innovations, epidemiological trends, regulatory changes and approvals, aging population dynamics, healthcare policies and reimbursement changes. Major trends in the forecast period include therapeutic innovation, epidemiological shifts, regulatory landscape, healthcare policies, advancements in diagnosis and monitoring.
A sedentary lifestyle is a major driver of the growth of the anti-hypertensive drug market. Consumption of junk food, lack of proper healthy and balanced diet, and lack of proper sleep due to irregular work shifts have contributed to the increase in hypertension. Hypertension is the underlying factor for at least 45% of deaths due to heart disease and 51% of deaths due to stroke. Once the patient is diagnosed with hypertension, patients are required to use the drugs to control hypertension based on the severity of the condition. Furthermore, in June 2021, according to the World Health Organization data 2021, a Switzerland-based Government agency responsible for international public health, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. This creates a sustainable demand for the product and acts as a prominent driver for the growth of the market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp
The anti-hypertensive drugs market covered in this report is segmented –
1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators
2) By Disease Source: Primary Hypertension, Secondary Hypertension
3) By End Users: Hospitals, Clinics, Homecare
Major companies operating in the anti-hypertensive drugs market are focusing on innovating new products, such as Metoprolol Succinate Extended-Release Tablets, to provide a competitive edge in the market. Metoprolol Succinate Extended-Release Tablets are used as anti-hypertensive drugs for patients with hypertension. For instance, in June 2023, Granules India Limited, an Indian-based pharmaceutical manufacturing company, launched Metoprolol Succinate Extended-Release Tablets approved by the Food and Drug Administration (FDA), a US-based federal agency. Metoprolol Succinate Extended-Release Tablets are anti-hypertensive drugs designed for the treatment of hypertension in order to lower blood pressure. These tablets are available in varying strengths, including 25mg, 50mg, 100mg, and 200mg. This consists of beta-blockers that slow down the heart rate, reduce the workload on the heart, and lower blood pressure.
The anti-hypertensive drugs market report table of contents includes:
.
.
.
Top Major Players :
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The asset reliability software global market report 2024 from The Business Research Company provides comprehensive…
The aortic endograft global market report 2024 from The Business Research Company provides comprehensive market…
The advanced therapeutics pharmaceutical outsourcing global market report 2024 from The Business Research Company provides…
The vertical take-off and landing (vtol) uav global market report 2024 from The Business Research…
The solar cells global market report 2024 from The Business Research Company provides comprehensive market…
The security analytics global market report 2024 from The Business Research Company provides comprehensive market…